Back to Search Start Over

Radical radiotherapy for paediatric solid tumour metastases: An overview of current European protocols and outcomes of a SIOPE multicenter survey

Authors :
Lorenza Gandola
Stéphane Supiot
Aikaterini Alexopoulou
Semi Harrabi
Beate Timmermann
Henry Mandeville
Marzanna Chojnacka
Stéphanie Bolle
A. Napieralska
Giovanni Scarzello
Candan Demiröz Abakay
Anna Mussano
Jelena Bokun
Petra S. Kroon
Sophie C. Huijskens
Jordi Giralt
Geert O. Janssens
John H. Maduro
Laetitia Padovani
Mark N. Gaze
Line Claude
Alexandre Escande
Enrica Seravalli
Guided Treatment in Optimal Selected Cancer Patients (GUTS)
Institut Català de la Salut
[Huijskens SC, Kroon PS] Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands. [Gaze MN] Department of Oncology, University College London Hospitals, London, UK. [Gandola L] Paediatric Radiotherapy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. [Bolle S] Department of Radiation Oncology, Gustave Roussy, Villejuif, France. [Supiot S] Oncologie Radiotherapie, Institut de Cancérologie de l’Ouest, Nantes, France. [Giralt J] Servei d’Oncologia Radioteràpica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
Source :
European Journal of Cancer, 145, 121-131. ELSEVIER SCI LTD, Scientia
Publication Year :
2020

Abstract

Metàstasis; Pediatria; Radioteràpia Metástasis; Pediatría; Radioterapia Metastases; Paediatrics; Radiotherapy Purpose/objective About 20% of children with solid tumours (ST) present with distant metastases (DM). Evidence regarding the use of radical radiotherapy of these DM is sparse and open for personal interpretation. The aim of this survey was to review European protocols and to map current practice regarding the irradiation of DM across SIOPE-affiliated countries. Materials/methods Radiotherapy guidelines for metastatic sites (bone, brain, distant lymph nodes, lung and liver) in eight European protocols for rhabdomyosarcoma, non-rhabdomyosarcoma soft-tissue sarcoma, Ewing sarcoma, neuroblastoma and renal tumours were reviewed. SIOPE centres irradiating ≥50 children annually were invited to participate in an online survey. Results Radiotherapy to at least one metastatic site was recommended in all protocols, except for high-risk neuroblastoma. Per protocol, dose prescription varied per site, and information on delineation and treatment planning/delivery was generally missing. Between July and September 2019, 20/27 centres completed the survey. Around 14% of patients were deemed to have DM from ST at diagnosis, of which half were treated with curative intent. A clear cut-off for a maximum number of DM was not used in half of the centres. Regardless of the tumour type and site, conventional radiotherapy regimens were most commonly used to treat DM. When stereotactic radiotherapy was used, a wide range of fractionation regimens were applied. Conclusion Current radiotherapy guidelines for DM do not allow a consistent approach in a multicentre setting. Prospective (randomised) trials are needed to define the role of radical irradiation of DM from paediatric ST. Stichting Kinderen Kankervrij [project no. 343]. KiKa (Children Cancer Free) foundation, grant number 343 and title: Towards optimization of radiotherapy techniques for metastatic lesions in children stage IV disease. The funding source had no role in the study design, collection, analysis and interpretation of data, writing of this manuscript or the decision to submit the article for publication.

Details

ISSN :
18790852 and 09598049
Volume :
145
Database :
OpenAIRE
Journal :
European journal of cancer (Oxford, England : 1990)
Accession number :
edsair.doi.dedup.....95c8c396752442361905ca0b59f44229